HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Fetal adipokines, a burgeoning field of research within the realm of prenatal and developmental biology, encapsulate a multifaceted network of signalling molecules originating from adipose tissue during fetal gestation. This intricate system plays a pivotal role in shaping the intrauterine environment, exerting profound influences on embryonic growth, organogenesis, and metabolic programming. Comprising a diverse array of adipocyte-secreted factors such as adiponectin, leptin, resistin, and visfatin, fetal adipokines serve as crucial mediators of communication between maternal physiology and the developing fetus. The delicate balance of these adipokines orchestrates key processes like energy metabolism, immune modulation, and vascularization within the feto-maternal unit. Notably, disruptions in the equilibrium of fetal adipokines have been implicated in a spectrum of pregnancy-related complications, including gestational diabetes, preeclampsia, and fetal macrosomia. Researchers are delving into the intricate interplay between fetal adipokines and epigenetic mechanisms, unravelling how these molecular messengers imprint lasting effects on offspring health, potentially predisposing individuals to metabolic disorders later in life. As scientific inquiries burgeon, understanding the nuanced dynamics of fetal adipokines promises insights that may not only refine our comprehension of prenatal physiology but also open avenues for novel therapeutic interventions aimed at optimizing maternal-fetal health and mitigating the long-term consequences of aberrant adipokine signalling during gestation.
